AI Just Compressed 160 Years of Aging Research — Here's What They Found | Dr. David Sinclair
Dr. David Sinclair discusses how AI is accelerating aging research by 160 years, enabling his lab to screen 8 billion virtual molecules to find drug candidates that reverse cellular aging. The episode covers breakthrough evidence that aging is fundamentally an information degradation problem and reveals concrete progress toward treating age-related diseases like Alzheimer's, blindness, and paralysis—with human trials on the horizon. Sinclair explains the mechanism of cellular de-aging, shares results from mice and primates, and outlines realistic timelines for bringing these therapies to market.
Key takeaways
- • AI has compressed 160 years of drug discovery into months by replacing physical molecular synthesis with computational docking simulations that test billions of candidate molecules against protein structures, allowing labs to move from expensive gene therapies to affordable oral pills.
- • Aging is caused by information loss in cells—specifically, misplaced DNA methylation marks that cause cells to "forget" which genes to read—and can be reversed by reactivating an embryonic reset mechanism using three genes (OSK) that restore cells to 75-80% of their youthful state without triggering cancer.
- • Gene therapy has reversed blindness in monkeys by regrowing optic nerves with 100% regeneration (vs. 5% in prior studies), with human trials for treating age-related blindness and other nerve damage expected within years, suggesting a path forward for spinal injuries and ALS.
- • Fasting and ketone supplementation modify gene expression by increasing acetate and butyrate, which attach to histone proteins and alter methylation patterns; long-term fasting may slow aging, though exogenous ketone effects appear acute.
- • Mini human brains grown in lab dishes can be aged, given Alzheimer's mutations, and successfully de-aged using the chemical cocktail—restoring electrical activity—providing a faster testing model than mouse brains and eliminating the need for primate studies on this particular pathway.
- • NAD boosting dramatically improves egg quality in infertile women (2-3x improvement in recent clinical trial using IV NAD), pointing to a near-term application for age reversal in fertility; uterine de-aging is further off (multiple years into development).
- • The biggest non-technical bottleneck is funding and FDA regulation, not biology—trials require hundreds of millions of dollars and rigorous safety protocols, but Sinclair estimates an 80% probability of success in humans given monkey results.
Recommendations (9)
"We used a molecule doxycyc. It's used to treat Lyme disease, but we're using it over a matter of a few weeks or really six weeks to turn on those three genes OSK."
David Sinclair · ▶ 1:37:54
"You can measure the rate of aging by looking at how these methyls change over time. And it's called a DNA methylation clock if you want to look it up."
David Sinclair · ▶ 1:39:29
"Next one is resveratrol. That's a staple of mine for 15 years. I take about a gram of resveratrol."
David Sinclair · ▶ 1:51:24
"We recently added a couple of things to my father's regimen. One is nattokinase, which is an enzyme that comes from fermented soybeans."
David Sinclair · ▶ 1:57:04
More from these creators
The Fed Chair Just Admitted The Jobs Aren't Coming Back — Here's What Happens To Your Career Next
The Strait Of Hormuz Is Closed and Are We On The Brink Of Revolution?
Ray Dalio’s Chilling WW3 Prediction & Claude Mythos Threatens The Entire Internet
The Wealth Transfer Has Started — Panic Sellers Are Handing Fortunes to Buyers
America's 'Pilot Rescue' Happened 10km From Iran's Hidden Nuclear Weapons Stash
Iran Just Shot Down a US Fighter Jet — And the Rescue Mission Failed